Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Juvenile dermatomyositis].

F Sell-Salazar1

  • 1Servicio de Neurología, Hospital Nacional de Niños "Dr. Carlos Sáenz Herrera", San José, Costa Rica. sellma@racsa.co.cr

Revista De Neurologia
|May 4, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Neurocysticercosis in Costa Rican children: clinical experience and the importance of epidemiological surveillance].

Revista de neurologia·2004
Same author

[Attention deficit hyperactivity syndrome].

Revista de neurologia·2003
Same author

[Gilles de la Tourette syndrome].

Revista de neurologia·2000
Same author

[West syndrome].

Revista de neurologia·2000

Juvenile dermatomyositis is an autoimmune disease causing inflammation in muscles and skin, primarily affecting children. Autoimmune-driven vasculitis damages blood vessels, leading to potential complications.

Area of Science:

  • Rheumatology
  • Pediatrics
  • Immunology

Context:

  • Juvenile dermatomyositis (JDM) is a rare idiopathic inflammatory myopathy affecting children.
  • It presents as a multisystemic inflammatory condition primarily impacting muscles and skin.
  • The incidence is approximately 4 per million, with a higher prevalence in females and Caucasian populations, typically manifesting between 5 and 14 years of age.

Purpose:

  • To describe the key characteristics of juvenile dermatomyositis.
  • To highlight the underlying autoimmune vasculitis mechanism.
  • To outline potential complications and neuropathic manifestations.

Summary:

  • JDM involves acute or chronic inflammatory injury affecting muscles and skin.
  • The etiology remains unknown, but autoantibody-induced vasculitis is recognized as the cause of microvasculature damage.

Related Experiment Videos

  • Rare complications include neuropathic manifestations like cerebral vasculitis and peripheral neuropathy, stemming from the same autoimmune process.

    • Impact:

    • Understanding JDM's autoimmune basis is crucial for diagnosis and management.
    • Recognizing vasculitis as a key factor aids in predicting and potentially mitigating complications.
    • Further research into JDM etiology and treatment is warranted.